Acute Myeloid Leukemia with Mllt3-kmt2a

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]

  A Phase 2 clinical trial evaluating the combination of decitabine, cytarabine, and daunorubicin hydrochloride for treatment of Acute Myeloid…

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

  Phase 2 clinical trial evaluating erlotinib hydrochloride in relapsed or refractory acute myeloid leukemia has completed with posted results…

• CLINICAL_TRIALS trial_result · 2014-02-20
  Clinical Trial Update: Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

  Phase 2 trial evaluating decitabine as maintenance therapy after standard treatment in adults with previously untreated acute myeloid leukem…